In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms

References

• Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526–1530.
   PubMed Web of Science ®Google Scholar
• Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerg Infect Dis 2004; 10: 14–19.
   PubMed Web of Science ®Google Scholar
• Klepser ME. Candida resistance and its clinical relevance. Pharmacotherapy 2006; 26: 68S–75S.
   PubMed Web of Science ®Google Scholar
• Kwon Chung KJ, Bennett JE. Candidiasis. Kwon Chung KJ, Bennett JE, Medical Mycology. Philadelphia, PA: Lea and Febiger, 1992; 280–336.
   Google Scholar
• Ng KP, Madasamy M, Saw TL, . Candida biotypes isolated from clinical specimens in Malaysia. Mycopathologia 1999; 144: 135–140.
   Web of Science ®Google Scholar
• Panizo MM, Reviákina V, Dolande M, Selgrad S. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Med Mycol 2009; 47: 137–143.
   PubMed Web of Science ®Google Scholar
• Weems JJ Jr, Chamberland ME, Ward J, . Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 1987; 25: 1029–1032.
   PubMed Web of Science ®Google Scholar
• Khun DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilm formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 2002; 70: 878–888.
   PubMedGoogle Scholar
• Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003; 11: 30–36.
   PubMed Web of Science ®Google Scholar
• Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinical significant problem. FEMS Yeast Res 2006; 6: 979–986.
   PubMed Web of Science ®Google Scholar
• Ficker CE, Smith ML, Susiarti S, . Inhibition of human pathogenic fungi by members of Zingiberaceae used by the Kenyah (Indonesian Borneo). J Ethnopharmacol 2003; 85: 289–293.
   PubMed Web of Science ®Google Scholar
• Rocha AD, de Oliveira AB, de Souza Filho JD, Lombardi JA, Braga FC. Antifungal constituents of Clytostoma ramentaceum and Mansoa hirsuta. Phytother Res 2004; 18: 463–467.
   PubMed Web of Science ®Google Scholar
• Arras G, Usai M. Fungitoxic activity of 12 essential oils against four postharvest citrus pathogens: chemical analysis of Thymus capitatus oil and its effect in subatmospheric pressure conditions. J Food Prot 2001; 64: 1025–1029.
   PubMed Web of Science ®Google Scholar
• Chami N, Chami F, Bennis S, Trouillas J, Remmal A. Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats. Braz J Infect Dis 2004; 8: 217–226.
   PubMedGoogle Scholar
• Hwang JK, Shim JS, Pyun YR. Antibacterial activity of xanthorrhizol from Curcuma xanthorrhiza against oral pathogens. Fitoterapia 2000; 71: 321–323.
   PubMedGoogle Scholar
• Hwang JK, Shim JS, Baek NI, Pyun YR. Xanthorrhizol: a potential antibacterial agent from Curcuma xanthorrhiza against Streptococcus mutans. Planta Med 2000; 66: 196–197.
   PubMed Web of Science ®Google Scholar
• Kim SH, Hong KO, Chung WY, Hwang JK, Park KK. Abrogation of cisplatin-induced hepatotoxicity in mice by xanthorrhizol is related to its effect on the regulation of gene transcription. Toxicol Appl Pharmacol 2004; 196: 346–355.
   PubMed Web of Science ®Google Scholar
• Lim CS, Jin DQ, Mok H, . Antioxidant and antiinflammatory activities of xanthorrhizol in hippocampal neurons and primary cultured microglia. J Neurosci Res 2005; 82: 831–838.
   PubMed Web of Science ®Google Scholar
• Rukayadi Y, Lee K, Lee M, Yong D, Hwang JK. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B. FEMS Yeast Res 2009; 9: 1302–1311.
   PubMedGoogle Scholar
• Rukayadi Y, Yong D, Hwang JK. In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. J Antimicrob Chemother 2006; 57: 1231–1234.
   PubMed Web of Science ®Google Scholar
• Rukayadi Y, Hwang JK. In vitro anti-Malassezia activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. Lett Appl Microbiol 2007; 44: 126–130.
   PubMedGoogle Scholar
• Rukayadi Y, Hwang JK. In vitro antimycotic activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. against opportunistic filamentous fungi. Phytother Res 2007; 21: 434–438.
   PubMed Web of Science ®Google Scholar
• Rukayadi Y, Hwang JK. In vitro activity of xanthorrhizol against Streptococcus mutans biofilms. Lett Appl Microbiol 2006; 42: 400–404.
   PubMedGoogle Scholar
• Rukayadi Y, Hwang JK. Effect of coating the wells of a polystyrene microtiter plate with xanthorrhizol on the biofilm formation of Streptococcus mutans. J Basic Microbiol 2006; 46: 410–415.
   PubMedGoogle Scholar
• Yanti, Rukayadi Y, Lee K, . Anti-biofilm activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. against bacterial biofilms formed by saliva and artificial multi-species oral strains. Food Sci Biotechnol 2009; 18: 556–560.
   Google Scholar
• Pierce CG, Uppuluri P, Tristan AR, . A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 2008; 3: 1494–1500.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast-Second Edition: Approved Standard M27-A2. CLSI, Wayne, PA, USA, 2002.
   Google Scholar
• Bachmann SP, VandeWalle K, Ramage G, . In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002; 46: 3591–3596.
   PubMed Web of Science ®Google Scholar
• Chandra J, Mukherjee PK, Ghannoum MA. In vitro growth and analysis of Candida biofilms. Nat Protoc 2008; 3: 1909–1924.
   PubMed Web of Science ®Google Scholar
• Hawser SP, Norris H, Jessup CJ, Gannoum MA. Comparison of a 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT)) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 1998; 36: 1450–1452.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Prigitano A, Biraghi E, Viviani MA, FIMUA-ECMM Candidaemia Study Group. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production. J Antimicrob Chemother 2005; 56: 777–779.
   PubMed Web of Science ®Google Scholar
• Linos A, Berekaa MM, Reichelt R, . Biodegradation of cis-1 ,4-polyisoprene rubbers by distinct actinomycetes: microbial strategies and detail surface analysis. Appl Environ Microbiol 2000; 66: 1639–1645.
   PubMed Web of Science ®Google Scholar
• Mukherjee PK, Chandra J. Candida biofilm resistance. Drug Resist Updat 2004; 7: 301–309.
   PubMed Web of Science ®Google Scholar
• Shin S, Pyun MS. Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B. Phytother Res 2004; 18: 827–830.
   PubMed Web of Science ®Google Scholar
• Chami N, Bennis S, Chami F, Aboussekhra A, Remmal A. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. Oral Microbiol Immunol 2005; 20: 106–111.
   PubMedGoogle Scholar
• Agarwal V, Lal P, Pruthi V. Prevention of Candida albicans biofilm by plant oils. Mycopathologia 2008; 165: 13–19.
   PubMed Web of Science ®Google Scholar
• He M, Du M, Fan M, Bian Z. In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia 2007; 163: 137–143.
   PubMed Web of Science ®Google Scholar
• Helmerhorst EJ, Reijnders IM, van't Hof W, . Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agents Chemother 1999; 43: 702–704.
   PubMed Web of Science ®Google Scholar
• Wakabayashi H, Abe S, Teraguchi S, Hayasawa H, Yamaguchi H. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob Agents Chemother 1998; 42: 1587–1591.
   PubMed Web of Science ®Google Scholar
• Cohen BE. Amphotericin B toxicity and lethality: a tale of two channels. Int J Pharm 1998; 162: 95–106.
   Web of Science ®Google Scholar